Heparanase pretreatment attenuates endotoxin-induced acute lung injury in rats

Shock

Volumn 28, Issue 2, 2007, Pages 207-212

  Bashenko, Yulia ^a   Ilan, Neta ^a   Krausz, Michael M ^a   Vlodavsky, Israel ^a   Hirsh, Mark I ^a,b,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCSD MEDICAL CENTER   (United States)

Author keywords

Acute respiratory distress syndrome; Neutrophils; Sepsis; Systemic inflammation

Indexed keywords

CYTOKINE; ENDOTOXIN; HEPARANASE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME RELEASE; FUNCTIONAL MORPHOLOGY; HISTOPATHOLOGY; IN VITRO STUDY; LUNG; LUNG INJURY; LUNG LAVAGE; MALE; MORTALITY; NEUTROPHIL; NONHUMAN; RAT; SEPSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ANIMALS; CELL LINE; DRUG SYNERGISM; ENDOTOXINS; GLUCURONIDASE; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MALE; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 34547698920     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e3180311d84     Document Type: Article

References (37)

1. Bone RC: Sepsis and its complications: the clinical problem. Crit Care Med 22:S8-S11, 1994.
2. Windsor AC, Mullen PG, Fowler AA, Sugerman HJ: Role of the neutrophil in adult respiratory distress syndrome. Br J Surg 80:10-17, 1993.
3. Downey GP, Dong Q, Kruger J, Dedhar S, Cherapanov V: Regulation of neutrophil activation in acute lung injury. Chest 116:46S-54S, 1999.
4. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M: Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729-777, 1999.
5. Kjellen L, Lindahl U: Proteoglycans: structures and interactions. Annu Rev Biochem 60:443-475, 1991.
6. Parish CR, Hindmarsh EJ, Bartlett MR, Staykova MA, Cowden WB, Willenborg DO: Treatment of central nervous system inflammation with inhibitors of basement membrane degradation. Immunol Cell Biol 76:104-113, 1998.
7. Vu TH, Werb Z: Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 14:2123-2133, 2000.
8. Werb Z: ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-442, 1997.
9. Pikas DS, Li JP, Vlodavsky I, Lindahl U: Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem 273:18770-18777, 1998.
10. Freeman C, Parish CR: Human platelet heparanase: purification, characterization and catalytic activity. Biochem J 330:1341-1350, 1998.
11. Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z: Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 12:112-127, 1992.
12. Matzner Y, Bar-Ner M, Yahalom J, Ishai-Michaeli R, Fuks Z, Vlodavsky I: Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. J Clin Invest 76:1306-1313, 1985.
13. Naparstek Y, Cohen IR, Fuks Z, Vlodavsky I: Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature 310:241-244, 1984.
14. Vaday GG, Lider O: Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J Leukoc Biol 67:149-159, 2000.
15. Capila I, Linhardt RJ: Heparin-protein interactions. Angew Chem Int Ed Engl 41:391-412, 2002.
16. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I, Ilan N: Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem 279:23536-23541, 2004.
17. Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N: Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res 66:1455-1463, 2006.
18. Zetser A, Bashenko Y, Miao HQ, Vlodavsky I, Ilan N: Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res 63:7733-7741, 2003.
19. Brackett DJ, Schaefer CF, Tompkins P, Fagraeus L, Peters LJ, Wilson MF: Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock 17:273-284, 1985.
20. Hirsh M, Dyugovskaya L, Kaplan V, Krausz MM: Response of lung gammadelta T cells to experimental sepsis in mice. Immunology 112:153-160, 2004.
21. Hirsh M, Kaplan V, Dyugovskaya L, Krausz MM: Response of lung NK1.1-positive natural killer cells to experimental sepsis in mice. Shock 22:40-45, 2004.
22. Hirsh M, Carmel J, Kaplan V, Livne E, Krausz MM: Activity of lung neutrophils and matrix metalloproteinases in cyclophosphamide-treated mice with experimental sepsis. Int J Exp Pathol 85:147-157, 2004.
23. Lee CT, Fein AM, Lippmann M, Holtzman H, Kimbel P, Weinbaum G: Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. N Engl J Med 304:192-196, 1981.
24. 2 metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs. J Appl Physiol 61:2224-2229, 1986.
25. Metnitz PG, Bartens C, Fischer M, Fridrich P, Steltzer H, Druml W: Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 25:180-185, 1999.
26. Azoulay E, Darmon M, Delclaux C, Fieux F, Bornstain C, Moreau D, Attalah H, Le Gall JR, Schlemmer B: Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med 30:781-786, 2002.
27. Kuschert GS, Coulin F, Power CA, Proudfoot AE, Hubbard RE, Hoogewerf AJ, Wells TN: Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38:12959-12968, 1999.
28. Hoogewerf AJ, Kuschert GS, Proudfoot AE, Borlat F, Clark-Lewis I, Power CA, Wells TN: Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36:13570-13578, 1997.
29. Marshall LJ, Ramdin LS, Brooks T, Shute JK: Plasminogen activator inhibitor-1 supports IL-8 - mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes. J Immunol 171:2057-2065, 2003.
30. Nelson S, Summer WR: Innate immunity, cytokines, and pulmonary host defense. Infect Dis Clin North Am 12:555-567, 1998. vii.
31. Janardhan KS, Sandhu SK, Singh B: Neutrophil depletion inhibits early and late monocyte/macrophage increase in lung inflammation. Front Biosci 11:1569-1576, 2006.
32. Ward PA, Lentsch AB: Endogenous regulation of the acute inflammatory response. Mol Cell Biochem 234-235:225-228, 2002.
33. Capsoni F, Minonzio F, Ongari AM, Carbonelli V, Galli A, Zanussi C: Interleukin-10 down-regulates oxidative metabolism and antibody-dependent cellular cytotoxicity of human neutrophils. Scand J Immunol 45:269-275, 1997.
34. Latifi SQ, O'Riordan MA, Levine AD: Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 70:4441-4446, 2002.
35. Sotnikov I, Hershkoviz R, Grabovsky V, Ilan N, Cahalon L, Vlodavsky I, Alon R, Lider O: Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts. J Immunol 172:5185-5193, 2004.
36. Pengal RA, Ganesan LP, Wei G, Fang H, Ostrowski MC, Tridandapani S: Lipopolysaccharide-induced production of interleukin-10 is promoted by the serine/threonine kinase Akt. Mol Immunol 43:1557-1564, 2006.
37. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM, Flavell RA: Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci U S A 103:2274-2279, 2006.